PURE Bioscience, Inc. (PURE)
OTCMKTS: PURE · Delayed Price · USD
-0.0076 (-8.97%)
May 24, 2024, 1:36 PM EDT - Market closed

PURE Bioscience Statistics

Total Valuation

PURE has a market cap or net worth of $8.62 million. The enterprise value is $9.85 million.

Market Cap 8.62M
Enterprise Value 9.85M

Important Dates

The last earnings date was Wednesday, June 14, 2023, after market close.

Earnings Date Jun 14, 2023
Ex-Dividend Date n/a

Share Statistics

PURE has 111.86 million shares outstanding. The number of shares has increased by 0.45% in one year.

Shares Outstanding 111.86M
Shares Change (YoY) +0.45%
Shares Change (QoQ) n/a
Owned by Insiders (%) 40.45%
Owned by Institutions (%) n/a
Float 66.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.19
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.79
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.72

Current Ratio 1.72
Quick Ratio 1.47
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -52.55

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -335.91%
Return on Capital (ROIC) -660.63%
Revenue Per Employee $187,000
Profits Per Employee -$331,636
Employee Count 11
Asset Turnover 1.17
Inventory Turnover 6.72


In the past 12 months, PURE has paid $11,000 in taxes.

Income Tax 11,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.16% in the last 52 weeks. The beta is 0.15, so PURE's price volatility has been lower than the market average.

Beta (1Y) 0.15
52-Week Price Change -30.16%
50-Day Moving Average 0.08
200-Day Moving Average 0.10
Relative Strength Index (RSI) 48.19
Average Volume (30 Days) 22,349

Short Selling Information

The latest short interest is 222,969, so 0.20% of the outstanding shares have been sold short.

Short Interest 222,969
Short Previous Month 254,799
Short % of Shares Out 0.20%
Short % of Float 0.33%
Short Ratio (days to cover) 2.56

Income Statement

In the last 12 months, PURE had revenue of $2.06 million and -$3.65 million in losses. Loss per share was -$0.03.

Revenue 2.06M
Gross Profit 1.14M
Operating Income -3.57M
Pretax Income -3.65M
Net Income -3.65M
EBIT -3.26M
Loss Per Share -$0.03
Full Income Statement

Balance Sheet

The company has $632,000 in cash and $1.86 million in debt, giving a net cash position of -$1.23 million or -$0.01 per share.

Cash & Cash Equivalents 632,000
Total Debt 1.86M
Net Cash -1.23M
Net Cash Per Share -$0.01
Equity / Book Value -1.32M
Book Value Per Share -0.01
Working Capital 394,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.73 million and capital expenditures $4,000, giving a free cash flow of -$2.73 million.

Operating Cash Flow -2.73M
Capital Expenditures 4,000
Free Cash Flow -2.73M
FCF Per Share -$0.02
Full Cash Flow Statement


Gross margin is 55.23%, with operating and profit margins of -173.75% and -177.35%.

Gross Margin 55.23%
Operating Margin -173.75%
Pretax Margin -177.20%
Profit Margin -177.35%
EBITDA Margin -152.36%
EBIT Margin -158.39%
FCF Margin -132.62%

Dividends & Yields

PURE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.45%
Shareholder Yield -0.45%
Earnings Yield -42.30%
FCF Yield -31.63%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on August 15, 2012. It was a reverse split with a ratio of 1:8.

Last Split Date Aug 15, 2012
Split Type Reverse
Split Ratio 1:8


PURE has an Altman Z-Score of -179.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -179.43
Piotroski F-Score 3